Simulations Plus today announced a new funded collaboration with a large pharmaceutical partner to enhance PKPlus, its PK/TK modeling software program Funded customization project will enhance and simplify high-throughput processing of PK/TK datasets Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today […]

As a Partner, Timegate Offers its Customers Access to the Largest Global Raman Library and Identification Software from Bio-Rad OULU, Finland and HERCULES, Calif.–Timegate Instruments Ltd, developer and manufacturer of time-gated Raman spectrometers and Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that […]

Seven-year collaboration expands LabCorp’s use of QIAGEN’s QCI platform with QIAGEN’s Human Gene Mutation Database for rare and hereditary workflows Hilden, Germany, and Germantown, Maryland – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced an agreement with LabCorp® (NYSE: LH) to extend their current QIAGEN Clinical Insights (QCI) license with QIAGEN’s Human Gene Mutation Database […]

New extension enables researchers to explore the REAL Space of 11 billion readily accessible compounds directly from StarDrop CAMBRIDGE, UK, KIEV, UKRAINE and SANKT AUGUSTIN, GERMANY – Optibrium™, BioSolveIT™ and Enamine™, leading providers of software and services for drug discovery, today announce a three-way collaboration enabling efficient search of Enamine’s REAL Space directly from within Optibrium’s […]

DENVILLE, NJ and HERCULES, Calif. – Diagenode, Inc., a leading global provider of solutions for epigenetics research and sample preparation, and Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced a partnership in which Diagenode will offer Single-Cell ATAC-Seq (scATAC-Seq) Services, featuring Bio-Rad’s Droplet Digital […]

Bio-Rad recently made the following announcement Edinburgh Instruments Ltd Joins Bio-Rad’s KnowItAll Raman Spectral Identification Partner Program As a Partner, Edinburgh Instruments Ltd Will Offer Its Customers Access to the Raman Identification Software and Largest Raman Spectral Database from Bio-Rad HERCULES, Calif.–November 11, 2019–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life […]

SYRACUSE, N.Y. — SUNY Upstate Medical University and Leica Microsystems, Inc. have combined efforts to establish the Leica Microsystems Center of Excellence at SUNY Upstate. The new Center will support a mission to drive new discoveries and insights from scientific research performed using state-of-the-art imaging systems. A signing ceremony will take place Thursday afternoon, November 14, 2019, at Weiskotten […]

Spectrum Two™ FT-IR spectrometer and software part of scientific collaboration with eXXpedition WALTHAM, Mass. – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced its Spectrum Two™ FT-IR spectrometer solution is onboard a research trip led by eXXpedition, a not-for-profit organization running all-women sailing voyages investigating ocean plastic pollution causes and solutions. The […]

Cross-industry collaboration will accelerate digital solutions and support R&D innovation by customers CARLSBAD, Calif. — Thermo Fisher Scientific, the world leader in serving science, has become a member of the Pistoia Alliance, a global, not-for-profit alliance of life science companies, vendors, publishers and academic groups working to lower barriers to innovation in life science and healthcare […]

Lantern Pharma a clinical stage oncology biotech leveraging A.I. and machine learning genomics company has selected REPROCELL Inc. to provide drug screening and drug sensitivity services. BELTSVILLE, MD.: REPROCELL Inc. a stem cell and drug discovery company has announced today that they have been selected by Lantern Pharma to provided preclinical screening and drug sensitivity for its portfolio of oncology drugs. The collaboration […]